| pubmed-article:17205019 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:17205019 | lifeskim:mentions | umls-concept:C0003062 | lld:lifeskim |
| pubmed-article:17205019 | lifeskim:mentions | umls-concept:C0032105 | lld:lifeskim |
| pubmed-article:17205019 | lifeskim:mentions | umls-concept:C0005516 | lld:lifeskim |
| pubmed-article:17205019 | lifeskim:mentions | umls-concept:C0061187 | lld:lifeskim |
| pubmed-article:17205019 | lifeskim:mentions | umls-concept:C0243026 | lld:lifeskim |
| pubmed-article:17205019 | lifeskim:mentions | umls-concept:C0304231 | lld:lifeskim |
| pubmed-article:17205019 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:17205019 | pubmed:dateCreated | 2007-4-10 | lld:pubmed |
| pubmed-article:17205019 | pubmed:abstractText | Plasma gelsolin is a circulating actin-binding protein that serves a protective role against tissue injuries. Depletion of plasma gelsolin in systemic inflammation may contribute to adverse outcomes. We examined the role of plasma gelsolin in animal models of sepsis. | lld:pubmed |
| pubmed-article:17205019 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17205019 | pubmed:language | eng | lld:pubmed |
| pubmed-article:17205019 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17205019 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:17205019 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17205019 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17205019 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17205019 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17205019 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17205019 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:17205019 | pubmed:month | Mar | lld:pubmed |
| pubmed-article:17205019 | pubmed:issn | 0090-3493 | lld:pubmed |
| pubmed-article:17205019 | pubmed:author | pubmed-author:PerrellaMark... | lld:pubmed |
| pubmed-article:17205019 | pubmed:author | pubmed-author:StosselThomas... | lld:pubmed |
| pubmed-article:17205019 | pubmed:author | pubmed-author:ChungSu WolSW | lld:pubmed |
| pubmed-article:17205019 | pubmed:author | pubmed-author:WaxmanAaron... | lld:pubmed |
| pubmed-article:17205019 | pubmed:author | pubmed-author:LeePo-ShunPS | lld:pubmed |
| pubmed-article:17205019 | pubmed:author | pubmed-author:CotichKara... | lld:pubmed |
| pubmed-article:17205019 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:17205019 | pubmed:volume | 35 | lld:pubmed |
| pubmed-article:17205019 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:17205019 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:17205019 | pubmed:pagination | 849-55 | lld:pubmed |
| pubmed-article:17205019 | pubmed:meshHeading | pubmed-meshheading:17205019... | lld:pubmed |
| pubmed-article:17205019 | pubmed:meshHeading | pubmed-meshheading:17205019... | lld:pubmed |
| pubmed-article:17205019 | pubmed:meshHeading | pubmed-meshheading:17205019... | lld:pubmed |
| pubmed-article:17205019 | pubmed:meshHeading | pubmed-meshheading:17205019... | lld:pubmed |
| pubmed-article:17205019 | pubmed:meshHeading | pubmed-meshheading:17205019... | lld:pubmed |
| pubmed-article:17205019 | pubmed:meshHeading | pubmed-meshheading:17205019... | lld:pubmed |
| pubmed-article:17205019 | pubmed:meshHeading | pubmed-meshheading:17205019... | lld:pubmed |
| pubmed-article:17205019 | pubmed:meshHeading | pubmed-meshheading:17205019... | lld:pubmed |
| pubmed-article:17205019 | pubmed:meshHeading | pubmed-meshheading:17205019... | lld:pubmed |
| pubmed-article:17205019 | pubmed:meshHeading | pubmed-meshheading:17205019... | lld:pubmed |
| pubmed-article:17205019 | pubmed:meshHeading | pubmed-meshheading:17205019... | lld:pubmed |
| pubmed-article:17205019 | pubmed:meshHeading | pubmed-meshheading:17205019... | lld:pubmed |
| pubmed-article:17205019 | pubmed:meshHeading | pubmed-meshheading:17205019... | lld:pubmed |
| pubmed-article:17205019 | pubmed:meshHeading | pubmed-meshheading:17205019... | lld:pubmed |
| pubmed-article:17205019 | pubmed:meshHeading | pubmed-meshheading:17205019... | lld:pubmed |
| pubmed-article:17205019 | pubmed:meshHeading | pubmed-meshheading:17205019... | lld:pubmed |
| pubmed-article:17205019 | pubmed:meshHeading | pubmed-meshheading:17205019... | lld:pubmed |
| pubmed-article:17205019 | pubmed:year | 2007 | lld:pubmed |
| pubmed-article:17205019 | pubmed:articleTitle | Plasma gelsolin is a marker and therapeutic agent in animal sepsis. | lld:pubmed |
| pubmed-article:17205019 | pubmed:affiliation | Pulmonary and Critical Care Division Brigham and Women's Hospital, Boston, MA, USA. | lld:pubmed |
| pubmed-article:17205019 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:17205019 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17205019 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17205019 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17205019 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17205019 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17205019 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17205019 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17205019 | lld:pubmed |
